Psilocybin for the Treatment of Patients with Depression and Co-Occurring Alcohol Use Disorder

Explore groundbreaking research on psilocybin therapy through this 41-minute grand rounds presentation from Johns Hopkins Psychiatry and Behavioral Sciences. Learn about the therapeutic potential of psilocybin for treating patients with depression and co-occurring alcohol use disorder as presented by Frederick Barrett, Ph.D. Discover the latest findings in psychedelic therapy research, including clinical trial methodologies, treatment protocols, and outcomes for dual-diagnosis patients. Examine the neurobiological mechanisms underlying psilocybin's therapeutic effects, safety considerations, and the evolving landscape of psychedelic-assisted psychotherapy. Gain insights into how this innovative treatment approach addresses the complex interplay between mood disorders and substance use disorders, and understand the implications for future psychiatric practice and patient care.